Purdue's Motion To Dismiss Opioid Marketing Case Rejected

Introduction

Merrimack County Superior Court Judge John Kissinger rejected Purdue Pharma's motion to dismiss claims filed against it over opioid’s deceptive marketing in New Hampshire.

The county judge asserted that Purdue Pharma purposely downplayed the health risks of its opioid OxyContin and extensively marketed its benefits. The jury found the state's claims against the opioid manufacturer were not preempted by federal law, and they must face the trial to deal with opioid addiction accusations. Recently, Endo Pharmaceuticals announced to settle all opioid lawsuits filed against them in a separate track from the federal MDL.

More than 400 lawsuits associated with opioid injuries are centralized as a part of multidistrict litigation, MDL No. 2804 (In Re: National Prescription Opiate Litigation) in the Northern District of Ohio before U.S. District Judge Dan A. Polster. The first bellwether trial in the litigation has been scheduled for September 3, 2019.

Comments

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Purdue's Motion To Dismiss Opioid Marketing Case Rejected